Trending

SEHA’s Tawam Hospital Achieves Breakthrough in Treating Severe Pediatric Epilepsy

Al Ain:SEHA's Tawam Hospital has showcased a significant medical advancement in the treatment of an eight-year-old girl suffering from severe drug-resistant epilepsy (DRE). The condition, which resulted in over 100 seizures daily, had severely impacted her development and quality of life.

According to Emirates News Agency, despite the administration of anti-seizure medications, the young patient continued to experience frequent seizures, creating a substantial burden on her daily life and her family. The constant episodes impeded her ability to safely engage in normal childhood activities, necessitating a specialized evaluation by the hospital's pediatric neurology team.

The clinical team at SEHA's Tawam Hospital conducted an extensive assessment involving electroencephalography (EEG), magnetic resonance imaging, and genetic testing. These procedures aimed to gain a deeper understanding of the seizures' nature and to guide a personalized treatment plan. As a result of the assessment, the team optimized her medication regimen and explored additional treatment options for epilepsy that had not sufficiently responded to medication alone.

Integral to her treatment was the implantation of a vagus nerve stimulation (VNS) device. This adjunctive treatment delivers mild electrical impulses to the vagus nerve, potentially reducing seizure frequency and severity in patients with drug-resistant epilepsy. The patient's treatment was managed through coordinated multidisciplinary care, with continuous monitoring and follow-up to evaluate her response and adjust treatment as needed.

Dr. Anil Vasudev Israni, Consultant Paediatric Neurologist at Tawam Hospital, emphasized the necessity of a thorough assessment for children with DRE, as seizures may persist despite multiple medications. The comprehensive evaluation helps in understanding the type of epilepsy, identifying the most suitable treatment options, and developing a plan tailored to the child's clinical needs. Since the implementation of the treatment plan, the patient has stopped experiencing seizures and is gradually resuming age-appropriate activities.

Recent Post

Advertisement